CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation
We recognize that every patients journey is unique, and the effectiveness of GLP-1 medications can vary
At present, patients should be counselled that there is insufficient evidence to support safe use of these agents in pregnancy
Many people will also experience cognitive difficulties such as problems with vision, memory, thinking, or reasoning, the development of mental illnesses such as depression, or general changes in behavior
The MB System launched on March 15 in Japan for consumers, and will be available to customers in several other regions including Australia, Europe, and Mexico by April 25
The most common side effects include nausea, gastrointestinal discomfort, changes in appetite, and feeling full more quickly